Truist Financial’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$267M Buy
2,221,085
+172,264
+8% +$19.9M 0.36% 57
2025
Q4
$216M Buy
2,048,821
+395,679
+24% +$37.1M 0.29% 70
2025
Q3
$139M Sell
1,653,142
-140,573
-8% -$11.6M 0.19% 108
2025
Q2
$142M Sell
1,793,715
-342,545
-16% -$27.2M 0.21% 104
2025
Q1
$192M Sell
2,136,260
-1,211,541
-36% -$113M 0.31% 64
2024
Q4
$333M Sell
3,347,801
-112,994
-3% -$11.6M 0.52% 34
2024
Q3
$393M Sell
3,460,795
-302,348
-8% -$35.9M 0.62% 31
2024
Q2
$466M Buy
3,763,143
+17,797
+0.5% +$2.29M 0.71% 25
2024
Q1
$494M Sell
3,745,346
-25,978
-0.7% -$3.2M 0.75% 25
2023
Q4
$411M Sell
3,771,324
-289,465
-7% -$30M 0.65% 28
2023
Q3
$418M Buy
4,060,789
+73,170
+2% +$7.89M 0.7% 26
2023
Q2
$460M Sell
3,987,619
-968,800
-20% -$110M 0.76% 21
2023
Q1
$527M Sell
4,956,419
-198,798
-4% -$21.5M 0.91% 14
2022
Q4
$572M Sell
5,155,217
-86,427
-2% -$8.83M 1.01% 11
2022
Q3
$451M Buy
5,241,644
+84,826
+2% +$7.57M 0.87% 18
2022
Q2
$470M Sell
5,156,818
-46,051
-0.9% -$4.08M 0.86% 16
2022
Q1
$427M Buy
5,202,869
+83,517
+2% +$6.58M 0.67% 23
2021
Q4
$392M Sell
5,119,352
-80,721
-2% -$6.43M 0.6% 31
2021
Q3
$391M Sell
5,200,073
-42,357
-0.8% -$3.22M 0.64% 24
2021
Q2
$408M Sell
5,242,430
-199,087
-4% -$14.8M 0.67% 21
2021
Q1
$400M Buy
5,441,517
+481,361
+10% +$35.5M 0.7% 22
2020
Q4
$387M Buy
4,960,156
+119,042
+2% +$9.1M 0.74% 14
2020
Q3
$383M Sell
4,841,114
-306,810
-6% -$24M 0.84% 13
2020
Q2
$380M Buy
5,147,924
+142,543
+3% +$10.7M 0.85% 13
2020
Q1
$367M Buy
5,005,381
+176,263
+4% +$13.9M 0.97% 12
2019
Q4
$419M Buy
4,829,118
+4,716,225
+4,178% +$387M 0.85% 13
2019
Q3
$9.07M Sell
112,893
-455,926
-80% -$36.5M 0.16% 148
2019
Q2
$45.5M Buy
568,819
+6,494
+1% +$497K 0.79% 26
2019
Q1
$44.6M Buy
562,325
+17,882
+3% +$1.34M 0.8% 23
2018
Q4
$39.7M Buy
544,443
+3,857
+0.7% +$272K 0.81% 23
2018
Q3
$36.6M Sell
540,586
-31,023
-5% -$1.98M 0.66% 33
2018
Q2
$33.1M Sell
571,609
-14,734
-3% -$831K 0.63% 34
2018
Q1
$30.5M Sell
586,343
-1,981
-0.3% -$107K 0.58% 37
2017
Q4
$31.6M Sell
588,324
-12,430
-2% -$689K 0.59% 37
2017
Q3
$36.7M Sell
600,754
-8,785
-1% -$533K 0.71% 22
2017
Q2
$37.3M Sell
609,539
-7,229
-1% -$440K 0.74% 21
2017
Q1
$37.4M Sell
616,768
-10,724
-2% -$651K 0.75% 23
2016
Q4
$35.2M Sell
627,492
-32,936
-5% -$1.93M 0.72% 26
2016
Q3
$39.3M Sell
660,428
-5,642
-0.8% -$330K 0.81% 21
2016
Q2
$36.6M Sell
666,070
-30,966
-4% -$1.65M 0.77% 22
2016
Q1
$35.2M Buy
697,036
+76,255
+12% +$3.73M 0.91% 18
2015
Q4
$31.3M Sell
620,781
-11,499
-2% -$580K 0.81% 21
2015
Q3
$29.8M Buy
632,280
+216,732
+52% +$11.5M 0.77% 20
2015
Q2
$22.6M Buy
415,548
+82,148
+25% +$4.61M 0.61% 36
2015
Q1
$18.3M Buy
333,400
+10,265
+3% +$581K 0.53% 47
2014
Q4
$17.5M Buy
323,135
+6,435
+2% +$359K 0.51% 54
2014
Q3
$17.9M Sell
316,700
-13,539
-4% -$760K 0.54% 51
2014
Q2
$18.2M Sell
330,239
-12,013
-4% -$655K 0.55% 48
2014
Q1
$18.5M Sell
342,252
-23,821
-7% -$1.23M 0.58% 44
2013
Q4
$17.5M Sell
366,073
-18,029
-5% -$824K 0.56% 42
2013
Q3
$17.4M Sell
384,102
-65,666
-15% -$3M 0.62% 40
2013
Q2
$19.9M Buy
+449,768
New +$20.1M 0.74% 26

Other funds holding MRK

Truist Financial's MRK Position: Q1 2026 in Review

Truist Financial increased its Merck (MRK) stake by 8.4% in Q1 2026, buying an estimated $19.9M and bringing the position to 2,221,085 shares worth $267M. The position accounts for 0.36% of the portfolio, ranked #57.

Truist Financial first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $572M in Q4 2022. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Truist Financial held 2,221,085 shares of Merck worth $267M as of Q1 2026.
  • Truist Financial bought 172,264 Merck shares in Q1 2026, an estimated $19.9M.
  • Merck made up 0.36% of Truist Financial's portfolio in Q1 2026, its #57 holding.
  • Truist Financial first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Truist Financial's Merck position peaked at $572M in Q4 2022.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Truist Financial's 13F filing for Q1 2026, filed 27 Apr 2026.